. At the end of follow-up, 55% of the total cohort were off medication and in remission. Approximately 70% of those stopping medication remained seizure free. At the time of diagnosis, the best predictors of remission, determined by a multivariate analysis scoring system, were 1) age <12 years at onset, 2) normal intelligence, 3) no prior neonatal seizures, and 4) fewer than 21 seizures before treatment. Prediction was improved after 12 months follow-up, when a score for the seizure frequency between 6 and 12 months was included. Patients with absence and minor motor seizures were excluded from the study. Seizure type and the EEG were not of predictive value. (Camfield C, Camfield P et al. Outcome of childhood epilepsy: A population-based study with a simple predictive scoring system for those treated with medication.
COMMENT. During the study period, 1977-1985 , the number of seizurefree years required before mediction withdrawal was attempted changed from 4 to 2 years. The authors endorse the stopping of medica¬ tion after 2 seizure-free years, regardless of the predicted prognosis.
A social outcome of epilepsy study in 337 intellectually normal children included in this Nova Scotia population found school failure in 34%, mental health consultation in 22%, psychotropic medication used in 5%, unemployment 20%, and criminal conviction in 2%. Learning disorders and more than 21 seizures before treatment for epilepsy were predictive of an unfavorable social outcome, but seizure control and EEG were non-predictive. (Camfield C, Camfield P et al. T Pediatr Tune 1993; 122: 869-873) .
CARBAMAZEPINE AND SERUM LIPID LEVELS
The effects of carbamazepine on serum lipid levels in 36 previously untreated patients with recently diagnosed idiopathic epilepsy were evaluated in a 1 to 5-year follow-up study at the Departments of Neurology and Clinical Chemistry, University of Oulu, Finland. Serum cholesterol, high-density lipoprotein (HDL) cholesterol, and g-glutamyltransferase (GGT) levels increased after 2 months' carbamazepine treatment and remained high after 1 and 5 years follow-up. Cholesterol/HDL cholesterol ratios remained unchanged.
Serum low-density lipoprotein (LDL) cholesterol and triglycerides (TG) increased during the first year but were normal after 5
